Disease details

Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

4 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01407211 (ClinicalTrials.gov)	April 2011	14/2/2011	Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient	The Impact of Vitamin A Supplementation on Gene Expression of Cytokine Secreted by CD4+ T Lymphocyte in Multiple Sclerosis Patients	Relapsing Remitting Multiple Sclerosis	Dietary Supplement: vitamin A	Tehran University of Medical Sciences	NULL	Enrolling by invitation	20 Years	45 Years	Both	30	Phase 4	Iran, Islamic Republic of
2	NCT01705457 (ClinicalTrials.gov)	February 2010	9/10/2012	Impact of Vitamin A on RAR Gene Expression in Multiple Sclerosis	Impact of Vitamin A Supplementation on RAR Gene Expression in PBMC Cells in Multiple Sclerotic Patients	Relapsing Remitting Multiple Sclerosis	Drug: Dietary Supplement: vitamin A;Drug: placebo	Tehran University of Medical Sciences	NULL	Enrolling by invitation	20 Years	45 Years	Both	20	Phase 4	Iran, Islamic Republic of
3	NCT01417273 (ClinicalTrials.gov)	February 2010	17/11/2010	Impact of Vitamin A on Multiple Sclerosis (MS)	Impact of Vitamin A Supplementation on Disease Activity and Progression in Multiple Sclerotic (MS) Patients	Relapsing Remitting Multiple Sclerosis	Dietary Supplement: vitamin A;Drug: Drug: placebo	Tehran University of Medical Sciences	NULL	Enrolling by invitation	20 Years	45 Years	Both	100	Phase 4	Iran, Islamic Republic of
4	NCT01225289 (ClinicalTrials.gov)	October 2009	6/9/2010	Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis Patients	The Study of the Effects of Vitamin A Supplementation on Immune System and Th1/Th2 Balance in Patients With Multiple Sclerosis	Relapsing Remitting Multiple Sclerosis	Dietary Supplement: Vitamin A;Drug: Placebo	Tehran University of Medical Sciences	NULL	Completed	20 Years	45 Years	All	36	Phase 4	Iran, Islamic Republic of